400-921-8278
| Catalog_no | ADMC0947 |
| Product_name | Palbociclib |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 780.00/1000.00/1440.00 |
| Specificity | Target: CDK . Fields: Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Dilution | IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Purification | >98% |
| Concentration | 靶点：CDK;IC50： 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | PD0332991; PD-0332991; PD 0332991 |
| Observed_band | 447.53 |
| Notes | Palbociclib (PD-0332991) is an orally available pyridopyrimidine-derived cyclin-dependent kinase (CDK) inhibitor with potential antineoplastic activity. IC50: 11 nM (Cdk4), 16 nM (Cdk6)[1] |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
